Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
about
Shortcomings in the current treatment of epilepsyMood stabilizers in pregnancy and lactationNeurodevelopmental effects of fetal antiepileptic drug exposureAn Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment OutcomesImpact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.Focus on apoptosis to decipher how alcohol and many other drugs disrupt brain development.Comments on Motamedi G, Meador K. Epilepsy and cognition. Epilepsy & behavior 2003;4:S25-S28.Cognitive outcomes of prenatal antiepileptic drug exposure.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Reduced Adult Hippocampal Neurogenesis and Cognitive Impairments following Prenatal Treatment of the Antiepileptic Drug Valproic Acid.Neurological and psychiatric sequelae of developmental exposure to antiepileptic drugs.Exposure to antiepileptic drugs in utero and child development: a prospective population-based study.The use of central nervous system active drugs during pregnancy.Women with epilepsy planning pregnancy: we can improve outcomes by improving careAlcohol-induced apoptosis of oligodendrocytes in the fetal macaque brain.Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.Isoflurane-induced apoptosis of neurons and oligodendrocytes in the fetal rhesus macaque brain.Drug-Induced Apoptosis: Mechanism by which Alcohol and Many Other Drugs Can Disrupt Brain Development.Developmental neurotoxicity of alcohol and anesthetic drugs is augmented by co-exposure to caffeine.Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness.Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.Treating epilepsy in pregnant women.Managing Your Own Mood Lability: Use of Mood Stabilizers and Antipsychotics in Pregnancy.Neurological Complications of Pregnancy.Advancing pharmacologic treatment options for pharmacologic treatment options for children with epilepsy.Antiepileptic drugs alter the expression of placental carriers: An in vitro study in a human placental cell line.Effects of valproic acid on the placental barrier in the pregnant mouse: Optical imaging and transporter expression studies.The risks associated with the use of lamotrigine during pregnancy.Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database.Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy.Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics.Caffeine Augments Anesthesia Neurotoxicity in the Fetal Macaque Brain.Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study.
P2860
Q22305925-B74BCCC4-60A8-4D32-ACBA-1E1C3A079779Q26795394-B556375F-C7A9-4D1B-9509-F627B2B366D8Q28080703-4F8067E1-96CB-4143-A010-C14CF48BF0A0Q28081205-BE15FDD3-60CA-40F2-B482-7D7A218A3B5AQ30443028-729156CE-2737-4420-ADB8-3B039434BC79Q30540714-4114A6D5-D38C-40A4-90BC-0D0453C3387BQ33997437-1FB581FC-57F7-4C95-B0C4-3857E608B588Q35337890-25302FEC-18AF-41A8-8772-D926B791FB9FQ35762249-831411DE-A3F0-4C3D-9EDA-B07667D721B0Q35862776-02DC64CA-2A7C-41D6-B773-D17EAFD2685FQ35871433-7347B865-AF0E-44AB-8454-EB9BE8DF1976Q36490198-DBDCD84B-3C54-4FAD-A19C-ECB013935F98Q37153982-42F5E52E-2C75-4841-AFEB-AD461BB1A087Q37280003-251D15D8-6D5E-4B3E-A24D-00E52EAEF26AQ37372213-17B4C78D-1E56-4BEE-A735-D77A3FFCCCDAQ37485070-B0913D43-2409-44AA-8869-8AF5E5359037Q37515864-2DEA04B7-CE25-41BA-9694-B33EC43ABA52Q37609328-5C60FA5C-25C8-48D3-AF7A-A766A5AEBC2AQ37609532-2F402134-628A-4EDC-ADA7-CECB2FC08441Q37699463-3A3F0E15-A04E-483E-B401-47B807D643ABQ38128147-6EDEDA7F-4DC7-443A-B7C9-C244FF322CC7Q38191297-BDD57B0B-B7A2-4A5A-9FF1-2A1EEE43CBADQ38194574-E4925FC2-BCB2-4A97-9068-EEAD87F6D28DQ38674230-C56B83BB-FA69-484B-B28A-989451E4AFBBQ38845438-07E66453-3B20-480F-9624-E7059A6C37DDQ38850130-0B3B1779-0B31-4C6D-9203-4D2593A04304Q38868683-F4084348-0684-4F64-B265-C939B5D19277Q38871992-B00C525A-6E79-446C-90E2-6886659A5FBAQ39402217-BEDA1E2F-AC59-4CAB-AE0B-FEB46E54BEC3Q40691051-5D875E19-FF16-4614-B303-E5256AC4E21FQ41930806-66B250AF-6B2C-444C-906C-50FFC8619D63Q47940100-1377C849-F82A-4A11-9946-AECD3425ACFFQ54988588-5E288C33-35F3-4C78-9E39-F46CE789A81AQ55280682-1169F27B-DDB9-41DF-A3A8-906EEF056C6C
P2860
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
@ast
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
@en
type
label
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
@ast
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
@en
prefLabel
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
@ast
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
@en
P2093
P2860
P1433
P1476
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.
@en
P2093
D W Loring
J Clayton-Smith
J D Liporace
K J Meador
L A Kalayjian
M Privitera
N Browning
P2860
P304
P356
10.1212/WNL.0B013E318250D824
P407
P577
2012-04-04T00:00:00Z